Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil 9 in HIV and Solid Organ Transplant Patients
NCT03525210Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by UZ Leuven. Started Apr 2018; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT03525210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03525210.